医用大麻：使使用与循证医学方法保持一致。
Medical cannabis: aligning use to evidence-based medicine approach.
机构信息
Cannabis Clinical Research Institute, Soroka University Medical Center and Faculty of Health Sciences, Ben-Gurion University of the Negev, Israel.
出版信息
Br J Clin Pharmacol. 2018 Nov;84(11):2458-2462. doi: 10.1111/bcp.13657. Epub 2018 Aug 28.
Abstract
During the past decade we have been witnessing a rise in medical cannabis use, yet the evidence for the safety and efficacy of the various cannabinoid compounds is scarce. The State of Israel has always been at the forefront of clinical and translational research in support of Evidence Based Medicine. With respect to cannabis Israel has created a medical and regulatory environment that enables clinical studies with cannabis which may lead to improved Evidence Based use of these compounds. This opinion paper discusses selected studies into the safety and effects of cannabis derived products.
摘要
在过去的十年中，我们见证了医用大麻使用的增加，但各种大麻素化合物的安全性和疗效证据却很少。以色列在支持循证医学的临床和转化研究方面一直处于领先地位。在大麻方面，以色列创造了一个医疗和监管环境，使对大麻衍生产品的安全性和效果进行临床研究成为可能，这可能会导致这些化合物的使用更加循证。本文讨论了一些关于大麻素产品的安全性和效果的研究。
相似文献
1
Medical cannabis: aligning use to evidence-based medicine approach.医用大麻：使使用与循证医学方法保持一致。
Br J Clin Pharmacol. 2018 Nov;84(11):2458-2462. doi: 10.1111/bcp.13657. Epub 2018 Aug 28.
2
Cannabinoids for Treatment of MS Symptoms: State of the Evidence.大麻素治疗多发性硬化症症状：证据现状。
Curr Neurol Neurosci Rep. 2018 Jun 19;18(8):50. doi: 10.1007/s11910-018-0859-x.
3
Understanding Cannabis-Based Therapeutics in Sports Medicine.理解运动医学中的大麻素疗法。
Sports Health. 2020 Nov/Dec;12(6):540-546. doi: 10.1177/1941738120956604. Epub 2020 Sep 16.
4
Positive and Negative Effects of Cannabis and Cannabinoids on Health.大麻及大麻素对健康的正反影响。
Clin Pharmacol Ther. 2019 May;105(5):1139-1147. doi: 10.1002/cpt.1381. Epub 2019 Mar 12.
5
[Cannabinoids for neuropathic pain management].[用于神经性疼痛管理的大麻素]
Ugeskr Laeger. 2018 Feb 26;180(9).
6
Cannabinoids: for better and for worse
.大麻素：有好有坏。
Dialogues Clin Neurosci. 2020 Sep;22(3):201-204. doi: 10.31887/DCNS.2020.22.3/fthibaut.
7
Medicinal use of cannabis based products and cannabinoids.大麻制品和大麻素的药用
BMJ. 2019 Apr 4;365:l1141. doi: 10.1136/bmj.l1141.
8
Medical cannabis and cannabinoids in rheumatology: where are we now?医学大麻和大麻素在风湿病学中的应用：我们现在处于什么位置？
Expert Rev Clin Immunol. 2019 Oct;15(10):1019-1032. doi: 10.1080/1744666X.2019.1665997.
9
Medical use of cannabis products: Lessons to be learned from Israel and Canada.大麻产品的医学用途：从以色列和加拿大汲取的经验教训。
Schmerz. 2016 Feb;30(1):3-13. doi: 10.1007/s00482-015-0083-4.
10
Introduction to special issue: Therapeutic and abuse-related effects of cannabis and cannabinoids.特刊介绍：大麻和大麻素的治疗和滥用相关作用。
Exp Clin Psychopharmacol. 2019 Aug;27(4):299-300. doi: 10.1037/pha0000308.
引用本文的文献
1
State of the Science: Health Care Provider Communication of Cannabis Use Among Adults Living with Cancer.科学现状：癌症成年患者中医疗服务提供者关于大麻使用情况的沟通
J Cancer Educ. 2024 Aug 19. doi: 10.1007/s13187-024-02484-z.
2
Cannabinoids in Periodontology: Where Are We Now?牙周病学中的大麻素：我们目前的进展如何？
Antibiotics (Basel). 2023 Nov 30;12(12):1687. doi: 10.3390/antibiotics12121687.
3
Medical Cannabis Is Not Associated with a Decrease in Activities of Daily Living in Older Adults.医用大麻与老年人日常生活活动能力的下降无关。
Biomedicines. 2023 Oct 3;11(10):2697. doi: 10.3390/biomedicines11102697.
4
MASCC guideline: cannabis for cancer-related pain and risk of harms and adverse events.MASCC指南：大麻用于癌症相关疼痛及危害和不良事件风险
Support Care Cancer. 2023 Mar 6;31(4):202. doi: 10.1007/s00520-023-07662-1.
5
Neuroprotection of Cannabidiol, Its Synthetic Derivatives and Combination Preparations against Microglia-Mediated Neuroinflammation in Neurological Disorders.大麻二酚及其合成衍生物和联合制剂对神经退行性疾病中小胶质细胞介导的神经炎症的神经保护作用。
Molecules. 2022 Aug 4;27(15):4961. doi: 10.3390/molecules27154961.
6
Online information on medical cannabis is not always aligned with scientific evidence and may raise unrealistic expectations.关于医用大麻的在线信息并不总是与科学证据一致，可能会引发不切实际的期望。
J Cannabis Res. 2022 Jul 11;4(1):37. doi: 10.1186/s42238-022-00145-w.
7
Impact of cannabinoids on pregnancy, reproductive health, and offspring outcomes.大麻素对妊娠、生殖健康和后代结局的影响。
Am J Obstet Gynecol. 2022 Oct;227(4):571-581. doi: 10.1016/j.ajog.2022.05.056. Epub 2022 May 31.
8
Cannabinoid Formulations and Delivery Systems: Current and Future Options to Treat Pain.大麻素制剂和给药系统：治疗疼痛的当前和未来选择。
Drugs. 2021 Sep;81(13):1513-1557. doi: 10.1007/s40265-021-01579-x. Epub 2021 Sep 4.
9
-Based Oral Formulations for Medical Purposes: Preparation, Quality and Stability.用于医疗目的的口服制剂：制备、质量与稳定性
Pharmaceuticals (Basel). 2021 Feb 22;14(2):171. doi: 10.3390/ph14020171.
10
Phytocannabinoids Profile in Medicinal Cannabis Oils: The Impact of Plant Varieties and Preparation Methods.药用大麻油中的植物大麻素概况：植物品种和制备方法的影响
Front Pharmacol. 2020 Nov 13;11:570616. doi: 10.3389/fphar.2020.570616. eCollection 2020.
本文引用的文献
1
Medical Cannabis for Pediatric Moderate to Severe Complex Motor Disorders.
J Child Neurol. 2018 Aug;33(9):565-571. doi: 10.1177/0883073818773028. Epub 2018 May 16.
2
Prospective analysis of safety and efficacy of medical cannabis in large unselected population of patients with cancer.前瞻性分析医疗大麻在大型未选择癌症患者人群中的安全性和疗效。
Eur J Intern Med. 2018 Mar;49:37-43. doi: 10.1016/j.ejim.2018.01.023.
3
Epidemiological characteristics, safety and efficacy of medical cannabis in the elderly.老年人医用大麻的流行病学特征、安全性和疗效。
Eur J Intern Med. 2018 Mar;49:44-50. doi: 10.1016/j.ejim.2018.01.019.
4
Medical use of cannabis and cannabinoids containing products - Regulations in Europe and North America.医用大麻及含大麻素产品的使用 - 欧洲和北美的法规。
Eur J Intern Med. 2018 Mar;49:2-6. doi: 10.1016/j.ejim.2018.01.001. Epub 2018 Jan 10.
5
The role of Sativex in robotic rehabilitation in individuals with multiple sclerosis: Rationale, study design, and methodology.Sativex在多发性硬化症患者机器人康复中的作用：理论依据、研究设计与方法
Medicine (Baltimore). 2017 Nov;96(46):e8826. doi: 10.1097/MD.0000000000008826.
6
Medical Cannabis in Parkinson Disease: Real-Life Patients' Experience.帕金森病中的医用大麻：真实患者的体验
Clin Neuropharmacol. 2017 Nov/Dec;40(6):268-272. doi: 10.1097/WNF.0000000000000246.
7
Incretin secretion in humans is under the influence of cannabinoid receptors.人体内的肠促胰岛素分泌受大麻素受体的影响。
Am J Physiol Endocrinol Metab. 2017 Sep 1;313(3):E359-E366. doi: 10.1152/ajpendo.00080.2017. Epub 2017 Jun 27.
8
Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome.Dravet 综合征患者应用大麻二酚治疗耐药性癫痫发作的试验
N Engl J Med. 2017 May 25;376(21):2011-2020. doi: 10.1056/NEJMoa1611618.
9
Depression and anxiety among chronic pain patients receiving prescription opioids and medical marijuana.慢性疼痛患者接受处方类阿片和医用大麻后的抑郁和焦虑。
J Affect Disord. 2017 Aug 15;218:1-7. doi: 10.1016/j.jad.2017.04.026. Epub 2017 Apr 21.
10
Low-Dose Cannabidiol Is Safe but Not Effective in the Treatment for Crohn's Disease, a Randomized Controlled Trial.低剂量大麻二酚在克罗恩病治疗中安全但无效：一项随机对照试验
Dig Dis Sci. 2017 Jun;62(6):1615-1620. doi: 10.1007/s10620-017-4540-z. Epub 2017 Mar 27.
Zotero 插件